These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 21962745)

  • 1. DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.
    Yewdell JW
    Trends Immunol; 2011 Nov; 32(11):548-58. PubMed ID: 21962745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Translating DRiPs: MHC class I immunosurveillance of pathogens and tumors.
    Antón LC; Yewdell JW
    J Leukoc Biol; 2014 Apr; 95(4):551-62. PubMed ID: 24532645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-examining class-I presentation and the DRiP hypothesis.
    Rock KL; Farfán-Arribas DJ; Colbert JD; Goldberg AL
    Trends Immunol; 2014 Apr; 35(4):144-52. PubMed ID: 24566257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translating DRiPs: progress in understanding viral and cellular sources of MHC class I peptide ligands.
    Dolan BP; Bennink JR; Yewdell JW
    Cell Mol Life Sci; 2011 May; 68(9):1481-9. PubMed ID: 21416150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The DRiP hypothesis decennial: support, controversy, refinement and extension.
    Yewdell JW; Nicchitta CV
    Trends Immunol; 2006 Aug; 27(8):368-73. PubMed ID: 16815756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoribosomes: Where's there's fire, there's fire.
    Wei J; Yewdell JW
    Mol Immunol; 2019 Sep; 113():38-42. PubMed ID: 29361306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC class I antigen presentation of DRiP-derived peptides from a model antigen is not dependent on the AAA ATPase p97.
    Palmer AL; Dolan BP
    PLoS One; 2013; 8(7):e67796. PubMed ID: 23844095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective ribosomal products (DRiPs): a major source of antigenic peptides for MHC class I molecules?
    Yewdell JW; Antón LC; Bennink JR
    J Immunol; 1996 Sep; 157(5):1823-6. PubMed ID: 8757297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The PTAP sequence within the p6 domain of human immunodeficiency virus type 1 Gag regulates its ubiquitination and MHC class I antigen presentation.
    Hahn S; Setz C; Wild J; Schubert U
    J Immunol; 2011 May; 186(10):5706-18. PubMed ID: 21482733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribosomal Proteins Regulate MHC Class I Peptide Generation for Immunosurveillance.
    Wei J; Kishton RJ; Angel M; Conn CS; Dalla-Venezia N; Marcel V; Vincent A; Catez F; Ferré S; Ayadi L; Marchand V; Dersh D; Gibbs JS; Ivanov IP; Fridlyand N; Couté Y; Diaz JJ; Qian SB; Staudt LM; Restifo NP; Yewdell JW
    Mol Cell; 2019 Mar; 73(6):1162-1173.e5. PubMed ID: 30712990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compartmentalized MHC class I antigen processing enhances immunosurveillance by circumventing the law of mass action.
    Lev A; Princiotta MF; Zanker D; Takeda K; Gibbs JS; Kumagai C; Waffarn E; Dolan BP; Burgevin A; Van Endert P; Chen W; Bennink JR; Yewdell JW
    Proc Natl Acad Sci U S A; 2010 Apr; 107(15):6964-9. PubMed ID: 20351281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plumbing the sources of endogenous MHC class I peptide ligands.
    Yewdell JW
    Curr Opin Immunol; 2007 Feb; 19(1):79-86. PubMed ID: 17140786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synthesis of truncated polypeptides for immune surveillance and viral evasion.
    Cardinaud S; Starck SR; Chandra P; Shastri N
    PLoS One; 2010 Jan; 5(1):e8692. PubMed ID: 20098683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitating protein synthesis, degradation, and endogenous antigen processing.
    Princiotta MF; Finzi D; Qian SB; Gibbs J; Schuchmann S; Buttgereit F; Bennink JR; Yewdell JW
    Immunity; 2003 Mar; 18(3):343-54. PubMed ID: 12648452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Direct Major Histocompatibility Complex Class I Self-Antigen Presentation Induced by Chlamydia Infection.
    Cram ED; Simmons RS; Palmer AL; Hildebrand WH; Rockey DD; Dolan BP
    Infect Immun; 2016 Feb; 84(2):480-90. PubMed ID: 26597986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Interferons on Presentation of Defective Ribosomal Products as HLA Peptides.
    Komov L; Melamed Kadosh D; Barnea E; Admon A
    Mol Cell Proteomics; 2021; 20():100105. PubMed ID: 34087483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying the contribution of defective ribosomal products to antigen production: a model-based computational analysis.
    Bulik S; Peters B; Holzhütter HG
    J Immunol; 2005 Dec; 175(12):7957-64. PubMed ID: 16339531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flu DRiPs in MHC Class I Immunosurveillance.
    Wei J; Yewdell JW
    Virol Sin; 2019 Apr; 34(2):162-167. PubMed ID: 30456657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of mRNA translation in direct MHC class I antigen presentation.
    Apcher S; Manoury B; Fåhraeus R
    Curr Opin Immunol; 2012 Feb; 24(1):71-6. PubMed ID: 22341517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The nature and extent of contributions by defective ribosome products to the HLA peptidome.
    Bourdetsky D; Schmelzer CE; Admon A
    Proc Natl Acad Sci U S A; 2014 Apr; 111(16):E1591-9. PubMed ID: 24715725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.